Активно (без набиране)
Фаза 1
2024-511346-39-00
Phase IB open label, long-term, extension basket trial of RAY121 to inhibit classical complement pathway in immunological diseases (RAINBOW-LTE trial)
Фаза 1 – тестване на безопасността при малка група хора
Заболявания:
Immune-mediated necrotizing myopathy
Antiphospholipid syndrome
Behçet’s Syndrome
Bullous pemphigoid
Dermatomyositis
Immune Thrombocytopenia
Спонсор: Chugai Pharmaceutical Co. Ltd.
Налично на:
БГ
EN